A young boy with Gaucher disease type 1 and hearing loss improved his hearing after receiving cochlear implants in both…
Articles by Joana Fernandes, PhD
The early diagnosis of children with Gaucher disease eligible for enzyme replacement therapy (ERT) helps decrease the incidence of severe complications…
The death of a 15-year-old boy with an aggressive form of heart-related Gaucher disease underscores the importance of early diagnosis…
The U.S. Food and Drug Administration (FDA) will now let Mountain View, Calif.-based 23andMe market its $199 genetic tests to…
Researchers have identified useful insights into the molecular workings underlying Gaucher disease that may reveal promising new targets for new therapeutic…
Combining oral Zavesca (miglustat) with intravenous enzyme replacement therapy (ERT) may prevent neurological problems in patients with neuronopathic Gaucher…
A man with type 1 Gaucher disease benefited after switching treatments to Zavesca (miglustat) from Cerezyme (imiglucerase), according to a case…
Magnetic resonance imaging (MRI) can be a resourceful tool to identify bone lesions in Gaucher disease (GD) patients, according to…
Understanding the progressive changes associated with Gaucher disease (GD) may provide useful information to develop more effective therapies. In recent…
Patients with type 1 Gaucher disease being treated with VPRIV (velaglucerase alfa) can safely transition to Cerdelga (eliglustat) or Cerezyme (imiglucerase)…